MENU
AVBP
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

ArriVent BioPharma (AVBP) Ownership - Who owns ArriVent BioPharma?

ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers... Show more

Profile

Industry
N/A
Address
18 Campus Boulevard
Phone
+1 628 277-4836
Employees
77
Web
https://www.arrivent.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
672.56M
P/E Ratio
-3.84
Total Cash
373.12M
Projected Growth
N/A
Total Debt
351K
Revenue
N/A
Risk (Beta)
N/A
Dividend Yield
N/A
Total Cash/Share
7.57
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Who owns ArriVent BioPharma? AVBP symbol Ownership - Tickeron.com